Gastrointestinal complications and extraintestinal manifestations of inflammatory bowel disease in Taiwan: A population-based study

被引:28
|
作者
Hsu, Yung-Cheng [1 ]
Wu, Tzee-Chung [1 ,2 ]
Lo, Yu-Cheng [1 ]
Wang, Li-Shu [1 ]
机构
[1] Taipei Vet Gen Hosp, Childrens Med Ctr, Div Gastroenterol, 201 Sect 2,Shih Pai Rd, Taipei 112, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan
关键词
Crohn's disease; extraintestinal manifestations; inflammatory bowel disease; ulcerative colitis; PYODERMA-GANGRENOSUM; CUTANEOUS MANIFESTATIONS; ULCERATIVE-COLITIS; COLORECTAL-CANCER; ERYTHEMA-NODOSUM; NATURAL-HISTORY; FOLLOW-UP; RISK; PATHOPHYSIOLOGY; EPIDEMIOLOGY;
D O I
10.1016/j.jcma.2016.08.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite a rising incidence of inflammatory bowel disease (IBD) in Taiwan, the clinical presentation of TBDs in this population has yet to be well characterized. Therefore, the aim of our study was to identify and describe the clinical features of gastrointestinal (GI) complications and extraintestinal manifestations (EIMs) of IBDs in the Taiwanese population. Methods: We conducted a retrospective study between 1998 and 2011, with relevant medical information extracted from the National Health Insurance Research Database. The diagnoses of IBD, GI complications, and EIMs were defined from the health registry using the appropriate International Classification of Diseases 9 codes. Results: A total of 3153 patients with IBDs were identified: 611 with Crohn's disease (CD) and 2542 with ulcerative colitis, with GI complications and EIMs identified in 22.2% and 11.9% of cases, respectively. CD was associated with an increased incidende of intestinal fistula, perforation, obstruction, peritonitis and perianal disease, and ulcerative colitis with benign neoplasm of the colon. Colorectal cancer developed in 0.35% of patients. Children with CD characteristically have more complex intestinal complications. The prevalence of EIMs was higher in females and in CD, with peripheral arthritis identified as the most common EIMs, overall. The rate of major EIMs affecting the articular, cutaneous, and visual systems was lower than the rate reported in Western countries. Conclusion: Our study found that CD had a more complicated course, with a higher incidence of GI complications and EIMS. However, the prevalence of intestinal complications, perianal disease, and major EIMS was less common than in Western countries. This study provided a distinct clinical feature of IBD in Taiwan. Copyright (C) 2016, the Chinese Medical Association. Published by Elsevier Taiwan LLC.
引用
收藏
页码:56 / 62
页数:7
相关论文
共 50 条
  • [41] The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based Study
    Kuo, Chia-Jung
    Yu, Kuang-Hui
    See, Lai-Chu
    Chiu, Cheng-Tang
    Su, Ming-Yao
    Hsu, Chen-Ming
    Kuo, Chang-Fu
    Chiou, Meng-Jiun
    Liu, Jia-Rou
    Wang, Hung-Wei
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (08) : 2454 - 2462
  • [42] The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based Study
    Chia-Jung Kuo
    Kuang-Hui Yu
    Lai-Chu See
    Cheng-Tang Chiu
    Ming-Yao Su
    Chen-Ming Hsu
    Chang-Fu Kuo
    Meng-Jiun Chiou
    Jia-Rou Liu
    Hung-Wei Wang
    Digestive Diseases and Sciences, 2015, 60 : 2454 - 2462
  • [43] Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients
    Salvarani, C
    Vlachonikolis, IG
    van der Heijde, DM
    Fornaciari, G
    Maechioni, P
    Beltrami, M
    Olivieri, I
    Di Gennaro, F
    Politi, P
    Stockbrügger, RW
    Russel, MG
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (12) : 1307 - 1313
  • [44] Correction to: Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Jurij Hanzel
    Christopher Ma
    Niels Vande Casteele
    Reena Khanna
    Vipul Jairath
    Brian G. Feagan
    Drugs, 2021, 81 : 1697 - 1697
  • [45] Diagnosis and Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease
    Gupta, Abhinav
    Choi, Sarah
    SURGICAL CLINICS OF NORTH AMERICA, 2025, 105 (02) : 385 - 404
  • [46] EXTRAINTESTINAL AND SYSTEMIC MANIFESTATIONS OF INFLAMMATORY BOWEL-DISEASE
    RANKIN, GB
    MEDICAL CLINICS OF NORTH AMERICA, 1990, 74 (01) : 39 - 50
  • [47] Therapies in Inflammatory Bowel Disease Patients with Extraintestinal Manifestations
    Juillerat, Pascal
    Manz, Michael
    Sauter, Bernhard
    Zeitz, Jonas
    Vavricka, Stephan R.
    DIGESTION, 2020, 101 (SUPPL 1) : 83 - 97
  • [48] Extraintestinal Manifestations in Children Diagnosed with Inflammatory Bowel Disease
    Kavcar, Zubeyr
    Civan, Hasret Ayyildiz
    Taskin, Didem Gulcu
    Hatipoglu, Sadik Sami
    MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2023, 57 (01): : 73 - 78
  • [49] EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
    Dimopoulos, Christina
    Hung, Kenneth
    Proctor, Deborah
    Ruggiero, Eilzabeth
    Al-Bawardy, Badr
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S19 - S20
  • [50] Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
    Livne-Margolin, M.
    Ling, D.
    Konyo, S. Attia
    Haj, O.
    Abitbol, C. M.
    Ben-Horin, S.
    Kopylov, U.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I429 - I430